纳米工程武装的型病毒驱动抗瘤反应:进展和挑战
Yan Zhang1,2, Xinyu Shi1,2, Yifan Shen1,2
1Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine University of Electronic Science and Technology of China Chengdu China.
MedComm
|October 14, 2024
概括
工程化瘤解毒病毒 (OVs) 通过选择性地破坏瘤细胞,在癌症治疗中表现有前途. 纳米工程增强了OV稳定性和瘤向性,提高了下一代癌症治疗的安全性和有效性.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 病毒学 病毒学
背景情况:
- 瘤病毒 (OV) 是一种有前途的癌症治疗模式,选择性向和溶解瘤细胞以诱导细胞死亡和瘤根除.
- 传统的OV疗法在病毒循环稳定性和瘤向性方面面临局限性,影响临床安全性和疗效.
- 纳米工程提供解决方案来克服这些局限性,提高OV的性能.
研究的目的:
- 为癌症治疗提供工程瘤解毒病毒 (OVs) 的综合分析.
- 探索工程化OVs抑制瘤进展的机制.
- 审查纳米材料,纳米技术和OV之间的协同作用,并确定未来的挑战和战略.
主要方法:
- 审查有关型病毒及其抗瘤机制的现有文献.
- 对OV应用的纳米工程策略的分析,包括纳米材料选择和纳米技术集成.
- 识别和讨论工程OV领域当前的挑战和建议的解决方案.
主要成果:
- 与传统的OV相比,工程化OV显示出增强的稳定性和瘤向能力.
- 纳米材料和纳米技术与OVs的结合为新型病毒设计提供了创新的方法.
- 了解工程化OVs的多方面的机制对于优化其抗瘤反应至关重要.
结论:
- 纳米工程解病毒代表了癌症治疗的重大进步,提供了更好的安全性和有效性.
- 对纳米材料和OVs的协同作用的持续研究对于开发下一代癌症治疗方法至关重要.
- 通过战略创新应对当前的挑战,将为工程化OV的更广泛应用铺平道路.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
2
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2
01:27Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857